Tevogen amends bylaws to reflect corporate name change to Tevogen IncPUBT·7 hours agoTVGN+13.13%TVGNW-7.37%
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquiredrttnews·2 days ago, 10:34 PMFBRX+0.59%TVGNW-7.37%
Tevogen Bio Announces 2026 Annual Meeting of Stockholders | TVGN Stock NewsStockTitan·Jul 13 at 01:15 PMTVGNW-7.37%TVGN+13.13%
Tevogen Announces Formation of a Healthcare Services Initiative | TVGN Stock NewsStockTitan·Jun 9 at 06:30 AMTVGN+13.13%TVGNW-7.37%
Tevogen Advances Strategic Acquisition Plans With Potential To Add $100 Million In Annual Revenuenasdaq·May 29 at 12:35 AMTVGNW-7.37%TVGN+13.13%
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue | TVGN Stock NewsStockTitan·May 28 at 03:30 AMTVGNW-7.37%TVGN+13.13%
Tevogen Bio Holdings shares are trading higher after the company announced it signed a non-binding Letter of Intent to evaluate a potential transaction with a Management Services Organization.benzinga_article·May 21 at 11:39 AMTVGNW-7.37%TVGN+13.13%
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization | TVGN Stock NewsStockTitan·May 21 at 03:15 AMTVGNW-7.37%TVGN+13.13%
Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock NewsStockTitan·May 18 at 03:15 AMTVGNW-7.37%TVGN+13.13%
